Global Melanoma Therapeutics Market
MarketDataForecast.com published a new research report on Global Melanoma Therapeutics Market that gives detailed information on Market Size and Growth
MarketDataForecast.com published a new research report on Global Melanoma Therapeutics Market that gives detailed information on Market Size and Growth
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
RESEARCH REPORT<br />
APRIL 2017<br />
GLOBAL MELANOMA THERAPEUTICS MARKET<br />
SEGMENTED BY TYPE AND SIZE, INDUSTRY ANALYSIS, SIZE,<br />
SHARE, GROWTH TRENDS AND FORECASTS 2016-2021
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
According to the report "<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong> ", published by <strong>Market</strong><br />
Data Forecast, the global market is projected to reach USD 4.63 billion by 2021, at a CAGR of<br />
15.80% from 2016 to 2021.<br />
The market for skin diseases and treatment is expanding substantially due to the mounting<br />
frequency of skin ailments such as skin cancer, skin infections, and skin allergies.<br />
<strong>Melanoma</strong> denotes to the type of skin cancer which forms from the pigment-consisting cells<br />
in the skin. It is more frequent in places with a sunny environment and is the most dangerous<br />
of all skin cancers. UV radiations are the main causes of melanoma. However, genes can also<br />
lead to melanoma. Even though, a plethora of treatment choices are accessible today, various<br />
immunotherapies and combination therapies are anticipated to arrive in the market. Large<br />
acceptance of these new treatments is projected due to their enhanced survival benefits and<br />
negligible side effects.<br />
Factors such as rise in melanoma cases, increasing awareness, high acceptance rate of<br />
therapeutics among patients, and government policies to provide better care for melanoma<br />
drive the growth of the <strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong>.<br />
The <strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> market is segmented based on cancer stage, cancer<br />
type, diagnosis and treatment.<br />
1) Based on cancer stage:<br />
Stage 0<br />
Stage I<br />
Stage II<br />
Stage III<br />
Stage IV<br />
2) Based on cancer type:<br />
<br />
<br />
<br />
<br />
<br />
<br />
Nodular melanoma<br />
Acral lentiginous melanoma<br />
Superficial spreading melanoma<br />
Lentigno maligna melanoma<br />
Amelanotic melanoma<br />
Others<br />
3) Based on diagnosis:<br />
<br />
<br />
<br />
<br />
<br />
<br />
Ultrasound<br />
Blood Tests<br />
Dermatoscopy<br />
Sentinel lymph node biopsy<br />
X-rays<br />
CT Scan<br />
4) Based on treatment:<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
<br />
<br />
Early melanoma<br />
Advanced melanoma<br />
a) Biological therapy<br />
b) Targeted therapy<br />
c) Surgery<br />
d) Chemotherapy<br />
e) Radiotherapy<br />
f) Immune therapy<br />
5) Geographical Segmentation:<br />
<br />
<br />
<br />
<br />
<br />
North America<br />
Europe<br />
Asia-Pacific<br />
Latin America<br />
Middle East and Africa<br />
The major companies operating in the global <strong>Melanoma</strong> <strong>Therapeutics</strong> market are Bristol-<br />
Myers Squibb Co., Merck and Co., F. Hoffmann-La Roche, Amgen Inc., Celgene Corp, Daiichi<br />
Sankyo, and Pfizer Inc.<br />
TABLE OF CONTENTS<br />
1. Introduction<br />
1.1 <strong>Market</strong> Definition<br />
1.2 Study Deliverables<br />
1.3 Base Currency, Base Year and Forecast Periods<br />
1.4 General Study Assumptions<br />
2. Research Methodology<br />
3. Overview<br />
2.1 Introduction<br />
2.2 Research Phases<br />
2.2.1 Secondary Research<br />
2.2.2 Primary Research<br />
2.2.3 Econometric Modelling<br />
2.2.4 Expert Validation<br />
2.3 Analysis Design<br />
2.4 Study Timeline<br />
3.1 Executive Summary<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
3.2 Key Inferences<br />
3.3 New Developments<br />
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)<br />
View report at http://www.marketdataforecast.com/market-reports/global-melanomatherapeutics-market-850/<br />
4.1 <strong>Market</strong> Drivers<br />
4.2 <strong>Market</strong> Restraints<br />
4.3 Key Challenges<br />
4.4 Current Opportunities in the <strong>Market</strong><br />
5. <strong>Market</strong> Segmentation<br />
5.1 By cancer stage<br />
5.1.1 Stage 0<br />
5.1.2 Stage I<br />
5.1.3 Stage II<br />
5.1.4 Stage III<br />
5.1.5 Stage IV<br />
Free sample of the report is available at http://www.marketdataforecast.com/marketreports/global-melanoma-therapeutics-market-850/request-sample<br />
5.2 By cancer type<br />
5.2.1 Nodular melanoma<br />
5.2.2 Acral lentiginous melanoma<br />
5.2.3 Superficial spreading melanoma<br />
5.2.4 Lentigno maligna melanoma<br />
5.2.5 Amelanotic melanoma<br />
5.2.6 Others<br />
5.3 By Diagnosis<br />
5.3.1 Ultrasound<br />
5.3.2 Blood Tests<br />
5.3.3 Dermatoscopy<br />
5.3.4 Sentinel lymph node biopsy<br />
5.3.5 X-rays<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
5.3.6 CT Scan<br />
5.4 By Treatment<br />
6. Geographical Analysis<br />
5.4.1 Early melanoma<br />
5.4.2 Advanced melanoma<br />
6.1 North America<br />
6.2 Europe<br />
5.4.2.1 Biological therapy<br />
5.4.2.2 Targeted therapy<br />
5.4.2.3 Surgery<br />
5.4.2.4 Chemotherapy<br />
5.4.2.5 Radiotherapy<br />
5.4.2.6 Immune therapy<br />
6.1.1 Introduction<br />
6.1.2 United States<br />
6.1.3 Canada<br />
6.2.1 Introduction<br />
Request Customization at http://www.marketdataforecast.com/market-reports/globalmelanoma-therapeutics-market-850/customize-report<br />
6.2.2 U.K<br />
6.2.3 Spain<br />
6.2.4 Germany<br />
6.2.5 Italy<br />
6.2.6 France<br />
6.3 Asia-Pacific<br />
Enquire more about the report at http://www.marketdataforecast.com/marketreports/global-melanoma-therapeutics-market-850/inquire<br />
6.3.1 Introduction<br />
6.3.2 China<br />
6.3.3 India<br />
6.3.4 Japan<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
6.3.5 South Korea<br />
6.3.6 Australia<br />
6.4 Latin America<br />
6.4.1 Introduction<br />
6.4.2 Brazil<br />
6.4.3 Argentina<br />
6.4.4 Mexico<br />
6.4.5 Rest of Latin America<br />
6.5 Middle East & Africa<br />
6.5.1 Introduction<br />
6.5.2 Middle-East<br />
6.5.3 Africa<br />
7. Pipeline Product Analysis<br />
Buy this report at https://www.marketdataforecast.com/cart/buy-now/globalmelanoma-therapeutics-market-850<br />
7.1 Overview<br />
7.2 Pipeline Development Landscape<br />
7.3 Molecular Targets in the Pipeline<br />
7.4 Clinical Trials<br />
7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and<br />
Molecular Target<br />
7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule<br />
Type and Molecular Target<br />
7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type<br />
and Molecular Target.<br />
8. Strategic Analysis<br />
8.1 PESTLE analysis<br />
8.1.1 Political<br />
8.1.2 Economic<br />
8.1.3 Social<br />
8.1.4 Technological<br />
8.1.5 Legal<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
8.1.6 Environmental<br />
8.2 Porter’s Five analysis<br />
8.2.1 Bargaining Power of Suppliers<br />
8.2.2 Bargaining Power of Consumers<br />
8.2.3 Threat of New Entrants<br />
8.2.4 Threat of Substitute Products and Services<br />
8.2.5 Competitive Rivalry within the Industry<br />
9. <strong>Market</strong> Leaders' Analysis<br />
9.1 Bristol-Myers Squibb Co<br />
9.1.1 Overview<br />
9.1.2 Product Analysis<br />
9.1.3 Strategic Evaluation and Operations<br />
9.1.4 Financial analysis<br />
9.1.5 Legal issues<br />
9.1.6 Recent Developments<br />
9.1.7 SWOT analysis<br />
9.1.8 Analyst View<br />
9.2 Merck and Co<br />
9.3 F. Hoffmann-La Roche<br />
9.4 Amgen Inc<br />
9.5 Celgene Corp<br />
9.6 Daiichi Sankyo<br />
9.7 Pfizer Inc<br />
10. Competitive Landscape<br />
10.1 <strong>Market</strong> share analysis<br />
10.2 Merger and Acquisition Analysis<br />
10.3 Agreements, collaborations and Joint Ventures<br />
10.4 New Product Launches<br />
11. Expert Opinions<br />
11.1 <strong>Market</strong> Outlook<br />
11.2 Investment Opportunities<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
<strong>Global</strong> <strong>Melanoma</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
Appendix<br />
a) List of Tables<br />
b) List of Figures<br />
SCOPE OF THE REPORT<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<strong>Global</strong>, regional and country-level analysis and forecasts of the study market;<br />
providing Insights on the major countries/regions in which this industry is blooming<br />
and to also identify the regions that are still untapped<br />
Segment-level analysis in terms of technology, component, and type along with<br />
market size forecasts and estimations to detect key areas of industry growth in detail<br />
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the<br />
market and their impact on shifting market dynamics<br />
Study of the effect of exogenous and endogenous factors that affect the global<br />
market; which includes broadly demographic, economics, and political, among other<br />
macro-environmental factors presented in an extensive PESTLE Analysis<br />
Study the micro environment factors that determine the overall profitability of an<br />
Industry, using Porter’s five forces analysis for analyzing the level of competition and<br />
business strategy development<br />
A comprehensive list of key market players along with their product portfolio, current<br />
strategic interests, key financial information, legal issues, SWOT analysis and analyst<br />
overview to study and sustain the market environment<br />
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in<br />
the field along with new product launches, comparative financial studies and recent<br />
developments in the market by the major companies<br />
An executive summary, abridging the entire report in such a way that decision-making<br />
personnel can rapidly become acquainted with background information, concise<br />
analysis and main conclusions<br />
Expertly devised analyst overview along with Investment opportunities to provide<br />
both individuals and organizations a strong financial foothold in the market<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
ABOUT US<br />
<strong>Market</strong> Data Forecast is a firm working in the areas of market research<br />
and business intelligence. We have rich experience in research across<br />
various business domains and we cater to the needs of both individual<br />
and corporate clients. Our research services assist clients in key<br />
business areas like business process improvement, key decision<br />
making and developing appropriate corporate strategy. We are truly<br />
committed to our clients and other stakeholders for providing<br />
customized research services of the highest quality.<br />
CONTACT INFORMATION<br />
We always look forward to working with new clients, pushing our<br />
boundaries and extending our reach beyond global horizons. Get in<br />
touch with us for further queries.<br />
Website: www.marketdataforecast.com<br />
E-Mail: contact@marketdataforecast.com<br />
Phone: +1 888-702-9626 (U.S Toll free),<br />
+91 7680952236 (Indian Office).<br />
FOR MORE INFORMATION<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
Change language